Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

A novel therapeutic peptide targeting myocardial reperfusion injury.

Boisguérin P, Covinhes A, Gallot L, Barrère C, Vincent A, Busson M, Piot C, Nargeot J, Lebleu B, Barrère-Lemaire S.

Cardiovasc Res. 2019 May 30. pii: cvz145. doi: 10.1093/cvr/cvz145. [Epub ahead of print]

PMID:
31147690
2.

Role of sociality in the response of killer whales to an additive mortality event.

Busson M, Authier M, Barbraud C, Tixier P, Reisinger RR, Janc A, Guinet C.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11812-11817. doi: 10.1073/pnas.1817174116. Epub 2019 May 20.

PMID:
31110009
3.

A Short SOX9 Peptide Mimics SOX9 Tumor Suppressor Activity and Is Sufficient to Inhibit Colon Cancer Cell Growth.

Blache P, Canterel-Thouennon L, Busson M, Verdié P, Subra G, Ychou M, Prévostel C.

Mol Cancer Ther. 2019 Aug;18(8):1386-1395. doi: 10.1158/1535-7163.MCT-18-1149. Epub 2019 May 15.

PMID:
31092563
4.

Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy.

Ladjohounlou R, Lozza C, Pichard A, Constanzo J, Karam J, Le Fur P, Deshayes E, Boudousq V, Paillas S, Busson M, Le Blay M, Jarlier M, Marcatili S, Bardiès M, Bruchertseifer F, Morgenstern A, Torgue J, Navarro-Teulon I, Pouget JP.

Clin Cancer Res. 2019 Aug 1;25(15):4775-4790. doi: 10.1158/1078-0432.CCR-18-3295. Epub 2019 May 6.

PMID:
31061069
5.

A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions.

Neiveyans M, Melhem R, Arnoult C, Bourquard T, Jarlier M, Busson M, Laroche A, Cerutti M, Pugnière M, Ternant D, Gaborit N, Chardès T, Poupon A, Gouilleux-Gruart V, Pèlegrin A, Poul MA.

MAbs. 2019 Apr;11(3):593-605. doi: 10.1080/19420862.2018.1564510. Epub 2019 Feb 18.

6.

Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.

Jeitany M, Leroy C, Tosti P, Lafitte M, Le Guet J, Simon V, Bonenfant D, Robert B, Grillet F, Mollevi C, El Messaoudi S, Otandault A, Canterel-Thouennon L, Busson M, Thierry AR, Martineau P, Pannequin J, Roche S, Sirvent A.

EMBO Mol Med. 2018 Apr;10(4). pii: e7918. doi: 10.15252/emmm.201707918.

7.

Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT.

Xhaard A, Cunha R, Busson M, Robin M, Dhedin N, Coman T, Cabannes-Hamy A, Sicre de Fontbrune F, Michonneau D, Socié G, Calado RT, Peffault de Latour R.

Blood Adv. 2017 Aug 2;1(18):1409-1413. doi: 10.1182/bloodadvances.2017008094. eCollection 2017 Aug 8.

8.

Antibody targeting of claudin-1 as a potential colorectal cancer therapy.

Cherradi S, Ayrolles-Torro A, Vezzo-Vié N, Gueguinou N, Denis V, Combes E, Boissière F, Busson M, Canterel-Thouennon L, Mollevi C, Pugnière M, Bibeau F, Ychou M, Martineau P, Gongora C, Del Rio M.

J Exp Clin Cancer Res. 2017 Jun 28;36(1):89. doi: 10.1186/s13046-017-0558-5.

9.

Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis.

Leconet W, Chentouf M, du Manoir S, Chevalier C, Sirvent A, Aït-Arsa I, Busson M, Jarlier M, Radosevic-Robin N, Theillet C, Chalbos D, Pasquet JM, Pèlegrin A, Larbouret C, Robert B.

Clin Cancer Res. 2017 Jun 1;23(11):2806-2816. doi: 10.1158/1078-0432.CCR-16-1316. Epub 2016 Dec 6.

10.

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.

Prévostel C, Rammah-Bouazza C, Trauchessec H, Canterel-Thouennon L, Busson M, Ychou M, Blache P.

Oncotarget. 2016 Dec 13;7(50):82228-82243. doi: 10.18632/oncotarget.10573.

11.

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors.

Martino S, Jamme M, Deligny C, Busson M, Loiseau P, Azoulay E, Galicier L, Pène F, Provôt F, Dossier A, Saheb S, Veyradier A, Coppo P; French Reference Center for Thrombotic Microangiopathies.

PLoS One. 2016 Jul 6;11(7):e0156679. doi: 10.1371/journal.pone.0156679. eCollection 2016.

12.

The p53 isoform Δ133p53β promotes cancer stem cell potential.

Arsic N, Gadea G, Lagerqvist EL, Busson M, Cahuzac N, Brock C, Hollande F, Gire V, Pannequin J, Roux P.

Stem Cell Reports. 2015 Apr 14;4(4):531-40. doi: 10.1016/j.stemcr.2015.02.001. Epub 2015 Mar 5.

13.

Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation.

Vives V, Cres G, Richard C, Busson M, Ferrandez Y, Planson AG, Zeghouf M, Cherfils J, Malaval L, Blangy A.

Nat Commun. 2015 Feb 3;6:6218. doi: 10.1038/ncomms7218.

PMID:
25645278
14.

The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancer. Validation using the mAb 12G4.

Kersual N, Garambois V, Chardès T, Pouget JP, Salhi I, Bascoul-Mollevi C, Bibeau F, Busson M, Vié H, Clémenceau B, Behrens CK, Estupina P, Pèlegrin A, Navarro-Teulon I.

MAbs. 2014;6(5):1314-26. doi: 10.4161/mabs.29316.

15.

Polymorphisms in oxidative stress-related genes are associated with nasopharyngeal carcinoma susceptibility.

Ben Chaaben A, Mariaselvam C, Salah S, Busson M, Dulphy N, Douik H, Ghanem A, Boukaouci W, Al Daccak R, Mamoghli T, Harzallah L, Bouassida J, Fortier C, Gritli S, Ben Hamida J, Charron D, Krishnamoorthy R, Guemira F, Tamouza R.

Immunobiology. 2015 Jan;220(1):20-5.

PMID:
25446398
16.

²⁰¹Tl⁺-labelled Prussian blue nanoparticles as contrast agents for SPECT scintigraphy.

Perrier M, Busson M, Massasso G, Long J, Boudousq V, Pouget JP, Peyrottes S, Perigaud Ch, Porredon-Guarch C, de Lapuente J, Borras M, Larionova J, Guari Y.

Nanoscale. 2014 Nov 21;6(22):13425-9. doi: 10.1039/c4nr03044c.

PMID:
25283238
17.

Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.

Itzykson R, Robin M, Moins-Teisserenc H, Delord M, Busson M, Xhaard A, de Fontebrune FS, Peffault de Latour R, Toubert A, Socié G.

Haematologica. 2015 Jan;100(1):114-23. doi: 10.3324/haematol.2014.113415. Epub 2014 Sep 26.

18.

Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.

Kheav VD, Busson M, Scieux C, Peffault de Latour R, Maki G, Haas P, Mazeron MC, Carmagnat M, Masson E, Xhaard A, Robin M, Ribaud P, Dulphy N, Loiseau P, Charron D, Socié G, Toubert A, Moins-Teisserenc H.

Haematologica. 2014 Dec;99(12):1860-7. doi: 10.3324/haematol.2014.108407. Epub 2014 Aug 1.

19.

Association between toll-like receptor 2 gene diversity and early-onset bipolar disorder.

Oliveira J, Hamdani N, Busson M, Etain B, Bennabi M, Amokrane K, Boukouaci W, Fortier C, Marzais F, Bengoufa D, Bellivier F, Henry C, Kahn JP, Charron D, Krishnamoorthy R, Le Corvoisier P, Leboyer M, Tamouza R.

J Affect Disord. 2014 Aug;165:135-41. doi: 10.1016/j.jad.2014.04.059. Epub 2014 May 4.

PMID:
24882191
20.

Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT.

Xhaard A, Moins-Teisserenc H, Busson M, Robin M, Ribaud P, Dhedin N, Abbes S, Carmagnat M, Kheav VD, Maki G, Peffault de Latour R, Toubert A, Socié G.

Bone Marrow Transplant. 2014 Aug;49(8):1089-92. doi: 10.1038/bmt.2014.105. Epub 2014 May 19.

PMID:
24842524
21.

Genetic diversity of TLR2, TLR4, and VDR loci and pulmonary tuberculosis in Moroccan patients.

Arji N, Busson M, Iraqi G, Bourkadi JE, Benjouad A, Bouayad A, Mariaselvam C, Salah S, Fortier C, Amokrane K, Marzais F, Boukouaci W, Krishnamoorthy R, Charron D, El Aouad R, Tamouza R.

J Infect Dev Ctries. 2014 Apr 15;8(4):430-40. doi: 10.3855/jidc.3820.

22.

Selective excitation of single molecules coupled to the bright mode of a plasmonic cavity.

Busson MP, Bidault S.

Nano Lett. 2014 Jan 8;14(1):284-8. doi: 10.1021/nl403963y. Epub 2013 Dec 6.

PMID:
24303895
23.

Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.

Leconet W, Larbouret C, Chardès T, Thomas G, Neiveyans M, Busson M, Jarlier M, Radosevic-Robin N, Pugnière M, Bernex F, Penault-Llorca F, Pasquet JM, Pèlegrin A, Robert B.

Oncogene. 2014 Nov 20;33(47):5405-14. doi: 10.1038/onc.2013.487. Epub 2013 Nov 18.

24.

Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis.

Clave E, Douay C, Coman T, Busson M, Bompoint C, Moins-Teisserenc H, Glauzy S, Carmagnat M, Gorin NC, Toubert A, Garderet L.

Leuk Lymphoma. 2014 Aug;55(8):1788-95. doi: 10.3109/10428194.2013.865182. Epub 2013 Dec 31.

PMID:
24237448
25.

Polymorphism of Toll-like receptor 4 gene in bipolar disorder.

Oliveira J, Busson M, Etain B, Jamain S, Hamdani N, Boukouaci W, Amokrane K, Bennabi M, Le Guen E, Dargél AA, Houenou J, Ivanova R, Bellivier F, Henry C, Kahn JP, Charron D, Krishnamoorthy R, Vervoitte L, Leboyer M, Tamouza R.

J Affect Disord. 2014 Jan;152-154:395-402. doi: 10.1016/j.jad.2013.09.043. Epub 2013 Oct 17.

PMID:
24176535
26.

Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb.

Boudousq V, Bobyk L, Busson M, Garambois V, Jarlier M, Charalambatou P, Pèlegrin A, Paillas S, Chouin N, Quenet F, Maquaire P, Torgue J, Navarro-Teulon I, Pouget JP.

PLoS One. 2013 Jul 29;8(7):e69613. doi: 10.1371/journal.pone.0069613. Print 2013.

27.

Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells.

Docquier A, Garcia A, Savatier J, Boulahtouf A, Bonnet S, Bellet V, Busson M, Margeat E, Jalaguier S, Royer C, Balaguer P, Cavaillès V.

Mol Endocrinol. 2013 Sep;27(9):1429-41. doi: 10.1210/me.2012-1351. Epub 2013 Jul 24.

28.

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center.

Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P; Thrombotic Microangiopathies Reference Center.

Transfusion. 2014 Feb;54(2):389-97. doi: 10.1111/trf.12263. Epub 2013 May 27.

PMID:
23711330
29.

CD19+CD5+ B cells and B1-like cells following allogeneic hematopoietic stem cell transplantation.

Moins-Teisserenc H, Busson M, Herda A, Apete S, Peffault de Latour R, Robin M, Xhaard A, Toubert A, Socié G.

Biol Blood Marrow Transplant. 2013 Jun;19(6):988-91. doi: 10.1016/j.bbmt.2013.03.006. Epub 2013 Mar 16.

30.

Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse.

Clave E, Lisini D, Douay C, Giorgiani G, Busson M, Zecca M, Moretta F, Acquafredda G, Brescia LP, Locatelli F, Toubert A.

Front Immunol. 2013 Mar 4;4:54. doi: 10.3389/fimmu.2013.00054. eCollection 2013.

31.

Kidney graft dysfunction in simultaneous pancreas-kidney recipients after pancreas failure: analysis of early and late protocol biopsies.

Viglietti D, Serrato T, Abboud I, Antoine C, Pillebout E, Busson M, Desgrandchamps F, Meria P, Godin M, Hurault de Ligny B, Thervet E, Legendre C, Suberbielle C, Verine J, Glotz D, Peraldi MN.

Clin Transplant. 2013 May-Jun;27(3):E249-55. doi: 10.1111/ctr.12095. Epub 2013 Feb 13.

PMID:
23406495
32.

The HLA-G low expressor genotype is associated with protection against bipolar disorder.

Debnath M, Busson M, Jamain S, Etain B, Hamdani N, Oliveira J, Boukouaci W, Amokrane K, Moins-Teisserenc H, Lajnef M, Bengoufa D, Malafosse A, Bellivier F, Henry C, Kahn JP, Krishnamoorthy R, Charron D, Leboyer M, Tamouza R.

Hum Immunol. 2013 May;74(5):593-7. doi: 10.1016/j.humimm.2012.11.032. Epub 2012 Dec 12.

33.

Photonic engineering of hybrid metal-organic chromophores.

Busson MP, Rolly B, Stout B, Bonod N, Wenger J, Bidault S.

Angew Chem Int Ed Engl. 2012 Oct 29;51(44):11083-7. doi: 10.1002/anie.201205995. Epub 2012 Oct 4.

PMID:
23037885
34.

Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer.

Bossard C, Busson M, Vindrieux D, Gaudin F, Machelon V, Brigitte M, Jacquard C, Pillon A, Balaguer P, Balabanian K, Lazennec G.

PLoS One. 2012;7(9):e44787. doi: 10.1371/journal.pone.0044787. Epub 2012 Sep 6. Erratum in: PLoS One. 2013;8(5). doi:10.1371/annotation/480acc26-456b-4e06-8cb6-2834bd6f5553.

35.

Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

Peffault de Latour R, Calado RT, Busson M, Abrams J, Adoui N, Robin M, Larghero J, Dhedin N, Xhaard A, Clave E, Charron D, Toubert A, Loiseau P, Socié G, Young NS.

Blood. 2012 Oct 18;120(16):3353-9. doi: 10.1182/blood-2012-01-403337. Epub 2012 Sep 4.

36.

Accelerated single photon emission from dye molecule-driven nanoantennas assembled on DNA.

Busson MP, Rolly B, Stout B, Bonod N, Bidault S.

Nat Commun. 2012 Jul 17;3:962. doi: 10.1038/ncomms1964.

PMID:
22805569
37.

Diastereomer configurations from joint experimental-computational analysis.

Aliev AE, Mia ZA, Busson MJ, Fitzmaurice RJ, Caddick S.

J Org Chem. 2012 Jul 20;77(14):6290-5. doi: 10.1021/jo301119h. Epub 2012 Jul 5.

PMID:
22734494
38.

A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype.

Payen D, Lukaszewicz AC, Legrand M, Gayat E, Faivre V, Megarbane B, Azoulay E, Fieux F, Charron D, Loiseau P, Busson M.

PLoS One. 2012;7(6):e35838. doi: 10.1371/journal.pone.0035838. Epub 2012 Jun 6.

39.

Long-term treatment with the pure anti-estrogen fulvestrant durably remodels estrogen signaling in BG-1 ovarian cancer cells.

Badia E, Docquier A, Busson M, Lapierre M, Pujol P, Balaguer P, Cavailles V.

J Steroid Biochem Mol Biol. 2012 Oct;132(1-2):176-85. doi: 10.1016/j.jsbmb.2012.05.006. Epub 2012 May 29.

40.

A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation.

Clave E, Lisini D, Douay C, Giorgiani G, Busson M, Zecca M, Charron D, Bernardo ME, Toubert A, Locatelli F.

Leukemia. 2012 Aug;26(8):1886-8. doi: 10.1038/leu.2012.59. Epub 2012 Mar 5. No abstract available.

PMID:
22430571
41.

Protein sequences involved in the mitochondrial import of the 3,5,3'-L-triiodothyronine receptor p43.

Carazo A, Levin J, Casas F, Seyer P, Grandemange S, Busson M, Pessemesse L, Wrutniak-Cabello C, Cabello G.

J Cell Physiol. 2012 Dec;227(12):3768-77. doi: 10.1002/jcp.24085.

PMID:
22392896
42.

Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation.

Sellathamby S, Lakshmi KM, Busson M, Viswabandya A, George B, Mathews V, Chandy M, Charron D, Krishnamoorthy R, Tamouza R, Srivastava A.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1219-26. doi: 10.1016/j.bbmt.2012.01.011. Epub 2012 Jan 16.

43.

The MCP-1 (CCL2) -2518 GG genotype is associated with protection against pulmonary tuberculosis in Moroccan patients.

Arji N, Busson M, Iraqi G, Bourkadi JE, Benjouad A, Boukouaci W, Lahlou O, Ben Amor J, Krishnamoorthy R, Charron D, El Aouad R, Tamouza R.

J Infect Dev Ctries. 2012 Jan 12;6(1):73-8.

44.

Photochemical grafting of diazonium salts on metals.

Busson M, Berisha A, Combellas C, Kanoufi F, Pinson J.

Chem Commun (Camb). 2011 Dec 21;47(47):12631-3. doi: 10.1039/c1cc16241a. Epub 2011 Oct 27.

PMID:
22031299
45.

Optical and topological characterization of gold nanoparticle dimers linked by a single DNA double strand.

Busson MP, Rolly B, Stout B, Bonod N, Larquet E, Polman A, Bidault S.

Nano Lett. 2011 Nov 9;11(11):5060-5. doi: 10.1021/nl2032052. Epub 2011 Oct 21.

PMID:
22011257
46.

Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita.

Zumelzu C, Le Roux-Villet C, Loiseau P, Busson M, Heller M, Aucouturier F, Pendaries V, Lièvre N, Pascal F, Brette MD, Doan S, Charron D, Caux F, Laroche L, Petit A, Prost-Squarcioni C.

J Invest Dermatol. 2011 Dec;131(12):2386-93. doi: 10.1038/jid.2011.231. Epub 2011 Aug 11.

47.

P43-dependent mitochondrial activity regulates myoblast differentiation and slow myosin isoform expression by control of Calcineurin expression.

Seyer P, Grandemange S, Rochard P, Busson M, Pessemesse L, Casas F, Cabello G, Wrutniak-Cabello C.

Exp Cell Res. 2011 Aug 15;317(14):2059-71. doi: 10.1016/j.yexcr.2011.05.020. Epub 2011 Jun 6.

PMID:
21664352
48.

Association of IL-12p40 +1188 A/C polymorphism with nasopharyngeal cancer risk and tumor extension.

Ben Chaaben A, Busson M, Douik H, Boukouaci W, Mamoghli T, Chaouch L, Harzallah L, Dorra S, Fortier C, Ghanem A, Charron D, Krishnamoorthy R, Guemira F, Tamouza R.

Tissue Antigens. 2011 Aug;78(2):148-51. doi: 10.1111/j.1399-0039.2011.01702.x. Epub 2011 May 30.

PMID:
21623733
49.

Association of HLA-G low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation.

Boukouaci W, Busson M, Fortier C, Amokrane K, de Latour RP, Robin M, Krishnamoorthy R, Toubert A, Charron D, Socié G, Tamouza R.

Front Immunol. 2011 Dec 27;2:74. doi: 10.3389/fimmu.2011.00074. eCollection 2011.

50.

NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation.

Haas P, Loiseau P, Tamouza R, Cayuela JM, Moins-Teisserenc H, Busson M, Henry G, Falk CS, Charron D, Socié G, Toubert A, Dulphy N.

Blood. 2011 Jan 20;117(3):1021-9. doi: 10.1182/blood-2010-02-269381. Epub 2010 Nov 2.

Supplemental Content

Loading ...
Support Center